Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Market Cap	53.73M
Revenue (ttm)	594.57K
Net Income (ttm)	-411.84K
Shares Out	68.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,932
Average Volume	5,316
Open	0.8100
Previous Close	0.9000
Day's Range	0.7800 - 0.8100
52-Week Range	0.2950 - 1.1000
Beta	0.07
RSI	46.67
Earnings Date	Mar 5, 2026

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and g...

• Industry: Food Distribution
• Sector: Consumer Staples
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.